Optain develops non-invasive, AI-enabled clinical support tools that analyse full‑colour retinal images to screen for referable eye diseases and evaluate broader health risks. Our mission is to increase access to early detection, improve diagnostic speed and consistency, and support clinicians with evidence‑based, easy‑to‑use technology.

We offer Eyetelligence Assure, a Software as a Medical Device (SaMD), combined with a portable automatic fundus camera as a turnkey solution. This all‑in‑one package captures high‑quality retinal images, applies validated AI algorithms in real time, and generates instant risk assessment reports to aid clinical decision making and population screening.

Optain is led by clinicians, scientists and engineers and is designed for healthcare providers, patients and payers. Our tools are intended to democratize access to specialized screening, reduce missed diagnoses, and enable scalable disease detection and risk stratification across clinical and insurance settings.